TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biolink Group AS
Closing information (x1000 DKK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
688
|
1,193
|
3,544 |
| Financial expenses |
1,118
|
1,055
|
870 |
| Earnings before taxes |
-6,047
|
-7,608
|
-8,472 |
| Total assets |
46,149
|
47,572
|
59,239 |
| Current assets |
4,860
|
6,433
|
18,112 |
| Current liabilities |
4,935
|
2,396
|
2,579 |
| Equity capital |
22,825
|
27,871
|
37,329 |
| - share capital |
3,773
|
3,972
|
4,232 |
| Employees (average) | 4 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
49.5%
|
58.6%
|
63.0% |
| Turnover per employee | 172 | ||
| Profit as a percentage of turnover |
-878.9%
|
-637.7%
|
-239.1% |
| Return on assets (ROA) |
-10.7%
|
-13.8%
|
-12.8% |
| Current ratio |
98.5%
|
268.5%
|
702.3% |
| Return on equity (ROE) |
-26.5%
|
-27.3%
|
-22.7% |
| Change turnover |
-445
|
-2,133
|
-433 |
| Change turnover % |
-39%
|
-64%
|
-11% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.